Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Trial Assessing the Impact of Double-strand Breaks on ART Outcomes and Predicting Its Clinical Thresholds

NCT07621991 is registered in ClinicalTrials.gov with Indira IVF Hospital Pvt Ltd as lead sponsor.

NCT NCT07621991
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07621991 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Trial Assessing the Impact of Double-strand Breaks on ART Outcomes and Predicting Its Clinical Thresholds
Lead sponsor
Indira IVF Hospital Pvt Ltd
Phase
Observational
Overall status
Not yet recruiting
Start date
June 1, 2026
Completion date
December 1, 2027
Enrollment
484 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

sperm dna fragmentation, sperm dna impact on art outcomes